NCT03413644View on ClinicalTrials.gov

Evaluation of ClearLLab Leukemia and Lymphoma Panels

CompletedOBSERVATIONAL
Enrollment

482

Participants

Timeline

Start Date

November 14, 2017

Primary Completion Date

April 27, 2018

Study Completion Date

April 27, 2018

Conditions
Leukemia-Lymphoma
Interventions
DIAGNOSTIC_TEST

Flow Cytometry

Immunophenotyping of residual clinical samples tested with ClearLLab diagnostic reagent on a specified Flow Cytometer

Trial Locations (4)

33913

NeoGenomics Laboratories, Inc., Fort Myers

81377

Munich Leukemia Laboratory, Munich

T2N 2T9

Calgary Laboratory Services, Calgary

N6A 5W9

London Health Sciences Center, London

Sponsors
All Listed Sponsors
lead

Beckman Coulter, Inc.

INDUSTRY